首页> 外文期刊>American journal of medical genetics, Part A >22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome?
【24h】

22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome?

机译:13qq在两名具有常见临床表现的患者中进行微复制:可识别的综合征?

获取原文
获取原文并翻译 | 示例
           

摘要

We report here on two unrelated patients (Patients 1 and 2) with a cryptic microduplication involving a 22q13 segment. Both patients manifested infantile hypotonia, developmental delay, and growth deficiency. In addition, an abnormal signal intensity area was detected in the frontal white matter of Patient 2 by brain MRI. Whole-genome microarray comparative genomic hybridization for Patient 1 and fluorescence in situ hybridization analysis with 22q-subtelomeric probes performed in both patients showed a submicroscopic 22q13 duplication that involved the SHANK3 gene. The duplication in Patient 1 was de novo type, while that in Patient 2 was derived from a familial 17;22 translocation. The presence of common clinical manifestations in the two patients with the common duplicated region led to a conclusion that 22q terminal duplication is a recognizable clinical entity, that is, the 22q13 microduplication syndrome.
机译:我们在这里报告了两名不相关的患者(患者1和2),这些患者涉及22q13区段的隐秘微复制。两名患者均表现出婴儿肌张力低下,发育迟缓和生长不足。另外,通过脑MRI在患者2的额白质中检测到异常信号强度区域。患者1的全基因组微阵列比较基因组杂交以及在两名患者中进行的22q-亚端粒探针的荧光原位杂交分析均显示涉及SHANK3基因的亚显微22q13复制。患者1中的重复是从头开始的,而患者2中的重复来自家族的17; 22易位。在具有共同重复区域的两名患者中共同临床表现的存在得出结论,即22q末端重复是可识别的临床实体,即22q13微复制综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号